Autoimmune Disease

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1236035

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1236035

Global Celiac Disease Drugs Market Size study & Forecast, by Drugs (First Line of Treatment and Second Line of Treatment) and Regional Analysis, 2022-2029

PUBLISHED: February 27, 2023

PAGES:

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Global Celiac Disease Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Celiac Disease or celiac sprue or gluten-sensitive enteropathy is a digestive problem that affects small intestine. Consumption of gluten triggers an immune response in the small intestine. There are different symptoms of Celiac disease including diarrhoea, bloating, wind, fatigue, low blood count (anaemia) and osteoporosis among others. The increasing incidence of Celiac Disease and growing investments in celiac disease awareness programs are key factors driving the market growth.

The increasing prevalence of Celiac Disease is contributing towards the expansion of Global Celiac Disease Treatment Market. For instance - as per Beyond Celiac Organization - in the United States an estimated 1 in 133 Americans, or about 1% of the population, has celiac disease. Moreover, as per the University of Chicago Medicine's Celiac disease Center estimates - in USA Celiac disease affects at least 3 million Americans. Also, increasing investment in healthcare sector in developing region and rising R&D activities related to celiac disease drugs would create lucrative growth prospectus for the market over the forecast period. However, stringent regulatory framework for drug approval stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Celiac Disease Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and increasing incidences of celiac diseases in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and the growing healthcare sector in the region.

Major market players included in this report are:

F. Hoffmann-La Roche
Merck & Co., Inc.
Johnson & Johnson
BiolineRx Ltd.
Pfizer Inc.
Innovate Biopharmaceuticals
ImmusanT, Inc.
Novartis AG
Bristol-Myers Squibb Company
Immunomedics, Inc.

Recent Developments in the Market:

In August 2019, the US Food and Drug Administration (FDA) approved an investigational new drug (IND) for oral ActoBiotics AG017 capsules from ActoBio Therapeutics. This new drug is an oral biologic drug candidate for the reversal of celiac disease.

Global Celiac Disease Drugs Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drugs, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drugs

First Line of Treatment
Second Line of Treatment

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Celiac Disease Drugs Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Celiac Disease Drugs Market, by Drugs, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Celiac Disease Drugs Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Celiac Disease Drugs Market Dynamics

3.1. Celiac Disease Drugs Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing incidence of Celiac Disease
  - 3.1.1.2. Growing investments in celiac disease awareness programs
- 3.1.2. Market Challenges
  - 3.1.2.1. Stringent regulatory framework for drug approval
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increasing investment in healthcare sector in developing region
  - 3.1.3.2. Rising R&D activities related to celiac disease drugs

Chapter 4. Global Celiac Disease Drugs Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Celiac Disease Drugs Market, by Drugs

6.1. Market Snapshot
6.2. Global Celiac Disease Drugs Market by Drugs, Performance - Potential Analysis
6.3. Global Celiac Disease Drugs Market Estimates & Forecasts by Drugs 2019-2029 (USD Billion)
6.4. Celiac Disease Drugs Market, Sub Segment Analysis
- 6.4.1. First Line of Treatment
- 6.4.2. Second Line of Treatment

Chapter 7. Global Celiac Disease Drugs Market, Regional Analysis

7.1. Celiac Disease Drugs Market, Regional Market Snapshot
7.2. North America Celiac Disease Drugs Market
- 7.2.1. U.S. Celiac Disease Drugs Market
  - 7.2.1.1. Drugs breakdown estimates & forecasts, 2019-2029
- 7.2.2. Canada Celiac Disease Drugs Market
7.3. Europe Celiac Disease Drugs Market Snapshot
- 7.3.1. U.K. Celiac Disease Drugs Market
- 7.3.2. Germany Celiac Disease Drugs Market
- 7.3.3. France Celiac Disease Drugs Market
- 7.3.4. Spain Celiac Disease Drugs Market
- 7.3.5. Italy Celiac Disease Drugs Market
- 7.3.6. Rest of Europe Celiac Disease Drugs Market
7.4. Asia-Pacific Celiac Disease Drugs Market Snapshot
- 7.4.1. China Celiac Disease Drugs Market
- 7.4.2. India Celiac Disease Drugs Market
- 7.4.3. Japan Celiac Disease Drugs Market
- 7.4.4. Australia Celiac Disease Drugs Market
- 7.4.5. South Korea Celiac Disease Drugs Market
- 7.4.6. Rest of Asia Pacific Celiac Disease Drugs Market
7.5. Latin America Celiac Disease Drugs Market Snapshot
- 7.5.1. Brazil Celiac Disease Drugs Market
- 7.5.2. Mexico Celiac Disease Drugs Market
- 7.5.3. Rest of Latin America Celiac Disease Drugs Market
7.6. Rest of The World Celiac Disease Drugs Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Company Profiles
- 8.2.1. F. Hoffmann La Roche
  - 8.2.1.1. Key Information
  - 8.2.1.2. Overview
  - 8.2.1.3. Financial (Subject to Data Availability)
  - 8.2.1.4. Product Summary
  - 8.2.1.5. Recent Developments
- 8.2.2. Merck & Co., Inc.
- 8.2.3. Johnson & Johnson
- 8.2.4. BiolineRx Ltd.
- 8.2.5. Pfizer Inc.
- 8.2.6. Innovate Biopharmaceuticals
- 8.2.7. ImmusanT, Inc.
- 8.2.8. Novartis AG
- 8.2.9. Bristol-Myers Squibb Company
- 8.2.10. Immunomedics, Inc.

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Celiac Disease Drugs Market, report scope
TABLE 2. Global Celiac Disease Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Celiac Disease Drugs Market estimates & forecasts by Drugs 2019-2029 (USD Billion)
TABLE 4. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 5. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Celiac Disease Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Celiac Disease Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. U.S. Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 16. U.S. Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. Canada Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. Canada Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. UK Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. UK Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. Germany Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. Germany Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. France Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. France Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. Italy Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. Italy Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Spain Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Spain Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. RoE Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. RoE Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. China Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. China Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. India Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. India Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. Japan Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. Japan Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. South Korea Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. South Korea Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. Australia Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. Australia Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. RoAPAC Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. RoAPAC Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. Brazil Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. Brazil Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Mexico Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Mexico Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. RoLA Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. RoLA Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. Row Celiac Disease Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. Row Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Celiac Disease Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Celiac Disease Drugs Market
TABLE 69. List of primary sources, used in the study of global Celiac Disease Drugs Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Celiac Disease Drugs Market, research methodology
FIG 2. Global Celiac Disease Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Celiac Disease Drugs Market, key trends 2021
FIG 5. Global Celiac Disease Drugs Market, growth prospects 2022-2029
FIG 6. Global Celiac Disease Drugs Market, porters 5 force model
FIG 7. Global Celiac Disease Drugs Market, pest analysis
FIG 8. Global Celiac Disease Drugs Market, value chain analysis
FIG 9. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Celiac Disease Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Celiac Disease Drugs Market, regional snapshot 2019 & 2029
FIG 15. North America Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
FIG 16. Europe Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Celiac Disease Drugs Market 2019 & 2029 (USD Billion)
FIG 19. Global Celiac Disease Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ